This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
MercadoLibre (MELI) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
MercadoLibre (MELI) first-quarter results benefit from strong performance of MercadoPago and MercadoEnvios.
Expedia Group (EXPE) Q1 Earnings Top, Revenues Lag Estimates
by Zacks Equity Research
Expedia Group's (EXPE) first-quarter results benefit from robust growth in stayed room nights. However, sluggish trivago performance impacts negatively.
What to Expect from Lumentum Holdings (LITE) in Q3 Earnings
by Zacks Equity Research
Lumentum Holdings' (LITE) third-quarter fiscal 2019 results are likely to benefit from strength in telecom, lasers and datacom revenues.
Avid Technology (AVID) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Avid Technology's (AVID) first-quarter 2019 results are likely to benefit from increasing recurring revenues, driven by growth in subscriptions and long-term agreements.
Trimble's (TRMB) Q1 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Trimble's (TRMB) first-quarter results benefit from well-performing transportation and building and infrastructure segments. However, economic slowdown in China remained a concern.
Maxim's (MXIM) Q3 Earnings In Line, Revenues Decline Y/Y
by Zacks Equity Research
Maxim (MXIM) witnesses momentum in automotive market but sluggish demand in industrial, data centre and consumer markets during the fiscal third quarter.
Square's (SQ) Q1 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Square's (SQ) first-quarter 2109 results benefit from robust contributions from Zesty and Weebly buyouts.
Why the Earnings Surprise Streak Could Continue for Agilent (A)
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AMETEK (AME) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMETEK's (AME) first-quarter 2019 results benefit from solid organic growth and positive contributions from acquisitions.
Square (SQ) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Square's (SQ) expanding seller base is likely to benefit its gross payment volume, which is expected to drive the top-line growth in first-quarter 2019.
What's in Store for AMETEK (AME) This Earnings Season?
by Zacks Equity Research
AMETEK's (AME) first-quarter results are likely to benefit from positive contributions from acquisitions.
Amtek (AME) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Amtek (AME) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Is Agilent (A) Up 5.3% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tencent (TCEHY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Tencent's (TCEHY) fourth-quarter results are likely to be hurt by the stalled video game approval process in China that was in place for the majority of 2018.
Booking Holdings (BKNG) Q4 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Booking Holdings' (BKNG) fourth-quarter results benefit from strong performance of its agency, merchant, advertising and other businesses.
Square (SQ) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Square's (SQ) fourth-quarter results gain from acquisition contributions, growing bitcoin revenues and robust product lines.
Top Ranked Momentum Stocks to Buy for February 28th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 28th:
Top Ranked Momentum Stocks to Buy for February 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 26th:
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
by Zacks Equity Research
The Zacks Analyst Blog Highlights: McDonald's, CVS Health, Celgene, Coca-Cola and Agilent
Top Ranked Momentum Stocks to Buy for February 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 25th:
Are You Looking for a Top Momentum Pick? Why Agilent Technologies (A) is a Great Choice
by Zacks Equity Research
Does Agilent Technologies (A) have what it takes to be a top stock pick for momentum investors? Let's find out.
Agilent (A) Upgraded to Buy: Here's Why
by Zacks Equity Research
Agilent (A) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Top Research Reports for McDonald's, CVS Health & Celgene
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including McDonald's (MCD), CVS Health (CVS) and Celgene (CELG).
Agilent (A) Surpasses Earnings and Revenue Estimates in Q1
by Zacks Equity Research
Agilent (A) reports strong fiscal first-quarter results on broad-based growth in all its product lines.
Agilent Technologies (A) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of 4.11% and 1.02%, respectively, for the quarter ended January 2019. Do the numbers hold clues to what lies ahead for the stock?